This content is PDF only. Please click on the PDF icon to access.
The Food and Drug Administration approved on 6 April 1970 three new drug applications for lithium carbonate. This approval is for its use in the control of manic episodes of manic depressive psychosis.
The available preparations (as of 1 June 1970) are these:
We reprint here the FDA summary of lithium carbonate, sent to practicing physicians by the FDA in April. This reprinting will bring this information to medical students and house officers and to physicians who overlooked the statement at its arrival in the mail.
A more detailed review of the development of lithium carbonate as a drug and
H. E. Current Drug Information: Lithium Carbonate. Ann Intern Med. 1970;73:291–293. doi: https://doi.org/10.7326/0003-4819-73-2-291
Download citation file:
Published: Ann Intern Med. 1970;73(2):291-293.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use